Nice
-
Guideline evidence on self-harm risk tools is described as uncertain
Critical analysis of NICE self-harm guidelines' methodological limitations, examining evidence gaps in risk assessment tool recommendations and the role of committee judgment versus empirical data.
-
Rivaroxaban controversy linked to synthetic certainty
Analysis of regulatory closure and synthetic certainization in rivaroxaban authorization, examining how institutional power consolidated therapeutic claims despite device defects.

